[1] Atwal GS, Bond GL, Metsuyanim S, Papa M, Friedman E, Distelman-Menachem T, Ben Asher E, Lancet D, Ross DA, Sninsky J, White TJ, Levine AJ, Yarden R. Haplotype structure and selection of the MDM2 oncogene in humans. Proc Natl Acad Sci USA, 2007, 104(11): 4524-4529.[2] Murphy ME. Polymorphic variants in the p53 pathway. Cell Death Differ, 2006, 13(6): 916-920.[3] Kay C, Jeyendran RS, Coulam CB. p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod Biomed Online, 2006, 13(4): 492-496.[4] Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature, 2007, 450(7170): 721-724.[5] Lin J, Wu X, Chen J, Chang A, Levine AJ. Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harb Symp Quant Biol, 1994, 59: 215-223.[6] Takahama Y, Ochiya T, Sasaki H, Baba-Toriyama H, Konishi H, Nakano H, Terada M. Molecular cloning and functional analysis of cDNA encoding a rat leukemia in-hibitory factor: towards generation of pluripotent rat em-bryonic stem cells. Oncogene, 1998, 16(24): 3189-3196.[7] Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer, 2009, 9(10): 724-737.[8] Feng Z, Zhang C, Kang HJ, Sun Y, Wang H, Naqvi A, Frank AK, Rosenwaks Z, Murphy ME, Levine AJ, Hu W. Regulation of female reproduction by p53 and its family members. FASEB J, 2011, 25(7): 2245-2255.[9] Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 1992, 359(6390): 76-79.[10] Cheng TC, Huang CC, Chen CI, Liu CH, Hsieh YS, Huang CY, Lee MS, Liu JY. Leukemia inhibitory factor antisense oligonucleotide inhibits the development of murine embryos at preimplantation stages. Biol Reprod, 2004, 70(5): 1270-1276.[11] Fry RC. The effect of leukaemia inhibitory factor (LIF) on embryogenesis. Reprod Fertil Dev, 1992, 4(4): 449-458.[12] Cheng JG, Rodriguez CI, Stewart CL. Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of im-plantation". Rev Endocr Metab Disord, 2002, 3(2): 119- 126.[13] Vogiagis D, Salamonsen LA, Sandeman RM, Squires TJ, Butt AR, Fry RC. Effect of immunisation against leukae-mia inhibitory factor on the establishment of pregnancy in sheep. Reprod Nutr Dev, 1997, 37(4): 459-468.[14] Gearing DP, Thut CJ, VandeBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J, 1991, 10(10): 2839-2848.[15] Nakamura H, Kimura T, Ogita K, Nakamura T, Takemura M, Shimoya K, Koyama S, Tsujie T, Koyama M, Murata Y. NF-kappaB activation at implantation window of the mouse uterus. Am J Reprod Immunol, 2004, 51(1): 16-21.[16] Bischof P, Haenggeli L, Campana A. Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol, 1995, 34(4): 225-230.[17] Bamberger AM, Jenatschke S, Schulte HM, LoningT, Bamberger MC. Leukemia inhibitory factor (LIF) stimu-lates the human HLA-G promoter in JEG3 choriocarci-noma cells. J Clin Endocrinol Metab, 2000, 85(10): 3932-3936.[18] Hirota Y, Daikoku T, Tranguch S, Xie H, Bradshaw HB, Dey SK. Uterine-specific p53 deficiency confers prema-ture uterine senescence and promotes preterm birth in mice. J Clin Invest, 2010, 120(3): 803-815.[19] Feng Z, Zhang C, Kang HJ, Sun Y, Wang H, Naqvi A, Frank AK, Rosenwaks Z, Murphy ME, Levine AJ, Hu W. Regulation of female reproduction by p53 and its family members. FASEB J, 2011, 25(7): 2244-2255.[20] Kang HJ, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ, Hu W. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proc Natl Acad Sci USA, 2009, 106(24): 9761-9766.[21] Choi J, Donehower LA. p53 in embryonic development: maintaining a fine balance. Cell Mol Life Sci, 1999, 55(1): 38-47.[22] Firouzabadi RD, Ghasemi N, Rozbahani MA, Tabibnejad N. Association of p53 polymorphism with ICSI/IVF fail-ure and recurrent pregnancy loss. Aust N Z J Obstet Gynaecol, 2009, 49(2): 216-219.[23] Goodman C, Jeyendran RS, Coulam CB. P53 tumor suppressor factor, plasminogen activator inhibitor, and vas-cular endothelial growth factor gene polymorphisms and recurrent implantation failure. Fertil Steril, 2009, 92(2): 494-498.[24] Shi H, Tan SJ, Zhong H, Hu W, Levine A, Xiao CJ, Peng Y, Qi XB, Shou WH, Ma RL, Li Y, Su B, Lu X. Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet, 2009, 84(4): 534-541.[25] Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and acceler-ates tumor formation in humans. Cell, 2004, 119(5): 591-602.[26] Kadakia M, Slader C, Berberich SJ. Regulation of p63 function by Mdm2 and MdmX. DNA Cell Biol, 2001, 20(6): 321-330.[27] Brooks CL, Li M, Hu M, Shi Y, Gu W. The p53-Mdm2-HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene, 2007, 26(51): 7262-7266.[28] Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T. p19 (ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Mol Cell Biol, 2002, 22(1): 370-377.[29] Xirodimas D, Saville MK, Edling C, Lane DP, Lain S. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene, 2001, 20(36): 4972-4983.[30] Ho GH, Calvano JE, Bisogna M, Abouezzi Z, Borgen PI, Cordon-Cardo C, van Zee KJ. Genetic alterations of the p14ARF-hdm2-p53 regulatory pathway in breast carci-noma. Breast Cancer Res Treat, 2001, 65(3): 225-232.[31] Kralickova M, Sima R, Vanecek T, Sima P, Rokyta Z, Ulcova-Gallova Z, Sucha R, Uher P, Hes O. Leukemia in-hibitory factor gene mutations in the population of infer-tile women are not restricted to nulligravid patients. Eur J Obstet Gynecol Reprod Biol, 2006, 127(2): 231-235.[32] Novotny Z, Krizan J, Sima R, Sima P, Uher P, Zech N, Hutelova R, Baborova P, Ulcova-Gallova Z, Subrt I, Ul-manova E, Houdek Z, Rokyta Z, BabuskaV, Kralickova M. Leukaemia inhibitory factor (LIF) gene mutations in women diagnosed with unexplained infertility and endo-metriosis have a negative impact on the IVF outcome. A pilot study. Folia Biol (Praha), 2009, 55(3): 92-97.[33] Levine AJ, Tomasini R, McKeon FD, MakTW, Melino G. The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol, 2011, 12(4): 259-265.[34] Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z, Elvin JA, Bronson RT, Crum CP, McKeon F. p63 protects the female germ line during meiotic arrest. Nature, 2006, 444(7119): 624-628.[35] Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C, Mattei M, Candi E, De Felici M, MelinoG, Cesareni G. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med, 2009, 15(10): 1179-1185.[36] Livera G, Petre-Lazar B, Guerquin MJ, Trautmann E, Coffigny H, Habert R. p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction, 2008, 135(1): 3-12.[37] Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontane-ous tumours. Nature, 2000, 404(6773): 99-103.[38] Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, Iovanna JL, Squire J, Jurisica I, Kaplan D, Melino G, JurisicovaA, Mak TW. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev, 2008, 22(19): 2677-2691.[39] Tomasini R, Mak TW, Melino G. The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol, 2008, 18(5): 244-252.[40] Tomasini R, Tsuchihara K, Tsuda C, Lau SK, Wilhelm M, Ruffini A, Tsao MS, Iovanna JL, Jurisicova A, MelinoG, Mak TW. TAp73 regulates the spindle assembly check-point by modulating BubR1 activity. Proc Natl Acad Sci USA, 2009, 106(3): 797-802. |